Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epothilone D in Second-Line Advanced Colorectal Cancer
NCT00077259Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Oct 2003
- Primary completion
- Sep 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Epothilone D in colorectal cancer (CRC), sponsored by Memorial Sloan Kettering Cancer Center. Started Oct 2003; status: completed.
02
Drugs
Epothilone D
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00077259.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00077259.